𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients

✍ Scribed by Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Petra Keilberg; Cristina Salvatori; Elisabetta Chiodi; Claudio Ascioti; Antonella Carollo; Vincenzo Positano; Massimo Lombardi

Publisher
BioMed Central
Year
2012
Tongue
English
Weight
124 KB
Volume
14
Category
Article
ISSN
1097-6647

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A T2* MRI prospective survey on heart ir
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Domenic πŸ“‚ Article πŸ“… 2011 πŸ› BioMed Central 🌐 English βš– 147 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprondesferrioxamine versus deferasirox.

A T2* MRI prospective survey on heart ir
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Anna Sp πŸ“‚ Article πŸ“… 2011 πŸ› BioMed Central 🌐 English βš– 292 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy.

A T2* MRI prospective survey on heart ir
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Luciano πŸ“‚ Article πŸ“… 2011 πŸ› BioMed Central 🌐 English βš– 284 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipronedesferrioxamine versus deferipron and desferrioxamine in monotherapy.